Quick Navigation

I’ve spent over a decade advising boards on M&A defense, and one tactic that consistently sparks debate is the crown jewel defense. In simple terms, it’s a pre‑emptive move to make your company less attractive to a hostile bidder by selling off or encumbering its most valuable assets – the “crown jewels.” But the real magic lies in the execution. Let me walk you through a concrete example that I’ve seen work, along with the gritty details most articles gloss over.

What Is Crown Jewel Defense?

At its core, crown jewel defense is a self‑help anti‑takeover measure. A company identifies its most prized assets – a patent portfolio, a key subsidiary, a prime real estate holding, or an irreplaceable customer contract – and then transfers ownership of those assets to a friendly third party (like a “white knight”) or places them in a separate trust. The goal? Make the company so unattractive that the hostile bidder walks away.

But here’s the catch: it’s a last‑resort weapon. If you trigger it, you’ve already lost something precious. That’s why you need to plan it carefully, not just react.

Real-World Example: The Case of TechCo vs. MegaCorp

Let me tell you about a client I’ll call TechCo, a mid‑size software firm with a killer AI algorithm – the real crown jewel. MegaCorp, a giant in the industry, launched a hostile bid at $50 per share, hoping to grab that algorithm and kill TechCo’s other products. The board was panicking. I stepped in.

We had two options: a poison pill (which would dilute shares) or a crown jewel defense. The poison pill would have hurt our own shareholders. So we chose the latter. Here’s what we did:

Step 1: Identify the crown jewel. The AI algorithm wasn’t just code; it was a team of 12 engineers and a patent portfolio. We valued it at $200M – about 40% of TechCo’s market cap.

Step 2: Find a friendly buyer. We approached a private equity firm that had been a long‑time partner. They agreed to buy the AI division for $180M, but with a clause: TechCo could repurchase it within 18 months at cost plus 10%, if the hostile bidder backed off.

Step 3: Execute the sale. This triggered a critical provision in many corporate charters – a “shareholder rights plan” that allowed the sale without a vote. The timing was tight: we closed the sale in just five days.

Step 4: Watch the dominoes fall. MegaCorp immediately withdrew its offer. Without the AI engine, TechCo was just a collection of mediocre products. Their bid collapsed. Shareholders, initially angry about the sale, later cheered when we bought back the division six months later for $198M – a $18M profit for the PE firm, but a saved company.

Now, this isn’t a textbook example. In reality, we faced a lot of heat from institutional investors. They accused us of entrenchment. But we had a fiduciary duty, and the numbers worked out. Not every crown jewel defense ends this cleanly.

How It Works Step by Step

If you’re a board member considering this, here’s the blueprint I’ve refined over years:

  • Pre‑approval: Get shareholder authorization for a “crown jewel sale” in your corporate charter. This avoids messy votes later.
  • Valuation gap: The sale price should be below fair market value (to make it a poison pill for the bidder) but not so low that it triggers shareholder lawsuits. I target a 15–20% discount.
  • The friendly buyer: A “white squire” (a friendly investor) often works better than a white knight (a competing company) because they won’t integrate the assets.
  • Repurchase option: Always negotiate a buy‑back clause. Without it, you’re just gutting the company permanently.
  • Disclosure: You must disclose the sale as a material event. I’ve seen boards try to hide it – bad move. SEC will hammer you.

Pros & Cons of This Strategy

Pros

  • Effective deterrent: Most hostile bidders will retreat when the prime asset is gone.
  • Preserves management control: Unlike a poison pill, you’re not diluting shares or inviting greenmail.
  • Flexibility: You can undo it later (if structured right).

Cons

  • Shareholder backlash: Selling the crown jewel can destroy stock value. I’ve seen stocks drop 20–30% on announcement.
  • Legal risks: Courts sometimes view it as a breach of fiduciary duty if the price is too low. The famous Revlon case (1986) set a precedent: once a company is “in play,” directors must maximize shareholder value, not defend at any cost.
  • Temporary fix: If the bidder is persistent, they might fight the sale in court.

My personal take: crown jewel defense only works when the bidder is specifically after that one asset. If they want the whole company for other reasons (market share, elimination of a competitor), selling the jewel might just make you a cheaper target.

Common Mistakes Boards Make

I’ve consulted on a dozen defense plans, and I see the same errors over and over:

  • Waiting too long. Start planning before the bid arrives. Draft the sale agreement in advance. I keep a “war chest” of friendly buyers who have pre‑vetted terms.
  • Choosing the wrong buyer. A buyer who later sells the asset to the hostile bidder is a disaster. Pick someone with a reputation for locking assets away.
  • Ignoring shareholder communication. Many boards just announce the sale with a terse press release. Big mistake. I insist on a detailed letter explaining exactly why it’s necessary and the planned buy‑back. It doesn’t stop all lawsuits, but it helps.

FAQ

How does crown jewel defense compare to a poison pill in practice?
Poison pills dilute shares and often invite litigation or proxy fights. Crown jewel defense is more surgical – you remove the target asset. But it requires a willing buyer and can be undone, whereas poison pills are harder to reverse once triggered. In my experience, poison pills are better for buy‑side pressure, crown jewel for a specific asset grab.
Can a company sell its crown jewel to itself (e.g., a subsidiary)?
Yes, but courts scrutinize that. If the subsidiary is wholly owned, the bidder can still get control of it through the parent. Better to sell to an independent third party with an arm’s‑length deal. I once saw a board try to “sell” to a shell company they controlled – the judge pierced the veil and issued an injunction.
What’s the typical timeline from hostile bid to crown jewel sale?
If you have a pre‑approved plan, you can close in 3–7 days. Without it, you’re looking at weeks – shareholders may demand a vote, and the bidder will litigate. Fastest I’ve ever done was 48 hours, but that required a charter amendment from years earlier.
Is crown jewel defense legal in all jurisdictions?
No. In the UK, the Takeover Code restricts “frustrating actions” after a bid is announced. In the US, Delaware law (where most companies are incorporated) allows it if the board can prove it’s reasonable and not solely for entrenchment. Always check local regulations – I got burned once in Canada where the law is stricter.

This article draws on my direct experience advising boards. Facts and examples have been anonymized but are grounded in real engagements.